25 XP   0   0   10

BGI Genomics Co Ltd
Buy, Hold or Sell?

Let's analyse Bgi together

PenkeI guess you are interested in BGI Genomics Co Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of BGI Genomics Co Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about BGI Genomics Co Ltd

I send you an email if I find something interesting about BGI Genomics Co Ltd.

Quick analysis of Bgi (30 sec.)










What can you expect buying and holding a share of Bgi? (30 sec.)

How much money do you get?

How much money do you get?
¥0.25
When do you have the money?
1 year
How often do you get paid?
84.4%

What is your share worth?

Current worth
¥24.17
Expected worth in 1 year
¥23.64
How sure are you?
78.1%

+ What do you gain per year?

Total Gains per Share
¥1.27
Return On Investment
3.3%

For what price can you sell your share?

Current Price per Share
¥38.08
Expected price per share
¥33.00 - ¥46.00
How sure are you?
50%

1. Valuation of Bgi (5 min.)




Live pricePrice per Share (EOD)

¥38.08

Intrinsic Value Per Share

¥-108.95 - ¥-131.32

Total Value Per Share

¥-84.78 - ¥-107.16

2. Growth of Bgi (5 min.)




Is Bgi growing?

Current yearPrevious yearGrowGrow %
How rich?$1.3b$1.3b$26.7m1.9%

How much money is Bgi making?

Current yearPrevious yearGrowGrow %
Making money$3.2m$27.7m-$24.5m-764.3%
Net Profit Margin2.2%12.9%--

How much money comes from the company's main activities?

3. Financial Health of Bgi (5 min.)




4. Comparing to competitors in the Diagnostics & Research industry (5 min.)




  Industry Rankings (Diagnostics & Research)  


Richest
#25 / 146

Most Revenue
#53 / 146

Most Profit
#58 / 146

What can you expect buying and holding a share of Bgi? (5 min.)

Welcome investor! Bgi's management wants to use your money to grow the business. In return you get a share of Bgi.

What can you expect buying and holding a share of Bgi?

First you should know what it really means to hold a share of Bgi. And how you can make/lose money.

Speculation

The Price per Share of Bgi is ¥38.08. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Bgi.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Bgi, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥24.17. Based on the TTM, the Book Value Change Per Share is ¥-0.13 per quarter. Based on the YOY, the Book Value Change Per Share is ¥0.47 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.45 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Bgi.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps0.010.0%0.010.0%0.070.2%0.080.2%0.060.2%
Usd Book Value Change Per Share-0.03-0.1%-0.020.0%0.070.2%0.100.3%0.100.3%
Usd Dividend Per Share0.000.0%0.060.2%0.040.1%0.030.1%0.020.1%
Usd Total Gains Per Share-0.03-0.1%0.040.1%0.110.3%0.120.3%0.130.3%
Usd Price Per Share6.63-7.92-8.89-11.62-10.58-
Price to Earnings Ratio220.28-448.60-43.41-183.45-140.13-
Price-to-Total Gains Ratio-227.30-184.83--662.90--20.37-52.38-
Price to Book Ratio1.99-2.35-2.71-5.03-5.47-
Price-to-Total Gains Ratio-227.30-184.83--662.90--20.37-52.38-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share5.262656
Number of shares190
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.060.03
Usd Book Value Change Per Share-0.020.10
Usd Total Gains Per Share0.040.12
Gains per Quarter (190 shares)8.3423.33
Gains per Year (190 shares)33.3593.31
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
147-1423207383
295-285641146176
3142-428961219269
4189-5612281292362
5236-70155102365455
6284-84188122438548
7331-98221142511641
8378-111254163584734
9426-125287183657827
10473-139320203730920

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%12.00.00.0100.0%19.01.00.095.0%31.01.00.096.9%31.01.00.096.9%
Book Value Change Per Share2.02.00.050.0%9.03.00.075.0%15.05.00.075.0%23.06.03.071.9%23.06.03.071.9%
Dividend per Share4.00.00.0100.0%12.00.00.0100.0%18.00.02.090.0%27.00.05.084.4%27.00.05.084.4%
Total Gains per Share3.01.00.075.0%10.02.00.083.3%16.04.00.080.0%25.05.02.078.1%25.05.02.078.1%

Fundamentals of Bgi

About BGI Genomics Co Ltd

BGI Genomics Co., Ltd. provides sequencing services and a portfolio of genetic tests for medical institutions, research institutions, and other public and private partners in China and internationally. The company offers DNA, RNA, and customized sequencing services; and non-invasive prenatal testing, reproductive health screening, newborn genetic screening, and clinical exome sequencing services, as well as clinical and research solutions for oncology. It also offers laboratory solutions for the detection and diagnosis of patients suspected with COVID-19; SARS-CoV-2 IgM and IgG antibody detection kit; and real-time fluorescent RT-PCR kit for detecting SARS-CoV-2. The company offers its services in various research areas, such as agriculture and food science, cancer research, metagenomics, reproductive health, biomarker discovery, and drug discovery. The company was formerly known as Shenzhen BGI Medicine Co., Ltd. and changed its name to BGI Genomics Co., Ltd. in 2015. BGI Genomics Co., Ltd. was founded in 1999 and is headquartered in Shenzhen, China.

Fundamental data was last updated by Penke on 2024-04-16 17:00:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is inefficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of BGI Genomics Co Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Bgi earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Bgi to the Diagnostics & Research industry mean.
  • A Net Profit Margin of 1.9% means that ¥0.02 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of BGI Genomics Co Ltd:

  • The MRQ is 1.9%. The company is making a profit. +1
  • The TTM is 2.2%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ1.9%TTM2.2%-0.3%
TTM2.2%YOY12.9%-10.7%
TTM2.2%5Y12.6%-10.4%
5Y12.6%10Y14.2%-1.6%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ1.9%-7.2%+9.1%
TTM2.2%-6.3%+8.5%
YOY12.9%1.3%+11.6%
5Y12.6%-2.2%+14.8%
10Y14.2%-1.4%+15.6%
1.1.2. Return on Assets

Shows how efficient Bgi is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Bgi to the Diagnostics & Research industry mean.
  • 0.2% Return on Assets means that Bgi generated ¥0.00 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of BGI Genomics Co Ltd:

  • The MRQ is 0.2%. Using its assets, the company is inefficient in making profit. -1
  • The TTM is 0.2%. Using its assets, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ0.2%TTM0.2%0.0%
TTM0.2%YOY1.5%-1.3%
TTM0.2%5Y2.2%-2.0%
5Y2.2%10Y2.0%+0.1%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2%-1.5%+1.7%
TTM0.2%-1.2%+1.4%
YOY1.5%-0.6%+2.1%
5Y2.2%-0.6%+2.8%
10Y2.0%-0.9%+2.9%
1.1.3. Return on Equity

Shows how efficient Bgi is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Bgi to the Diagnostics & Research industry mean.
  • 0.2% Return on Equity means Bgi generated ¥0.00 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of BGI Genomics Co Ltd:

  • The MRQ is 0.2%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 0.2%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ0.2%TTM0.2%0.0%
TTM0.2%YOY2.1%-1.9%
TTM0.2%5Y3.4%-3.1%
5Y3.4%10Y3.0%+0.4%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2%-0.5%+0.7%
TTM0.2%-+0.2%
YOY2.1%0.3%+1.8%
5Y3.4%-1.5%+4.9%
10Y3.0%-2.5%+5.5%

1.2. Operating Efficiency of BGI Genomics Co Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Bgi is operating .

  • Measures how much profit Bgi makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Bgi to the Diagnostics & Research industry mean.
  • An Operating Margin of 0.0% means the company generated ¥0.00  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of BGI Genomics Co Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM0.6%-0.6%
TTM0.6%YOY15.6%-14.9%
TTM0.6%5Y14.5%-13.9%
5Y14.5%10Y10.1%+4.4%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ--6.2%+6.2%
TTM0.6%-5.8%+6.4%
YOY15.6%4.8%+10.8%
5Y14.5%1.6%+12.9%
10Y10.1%-2.0%+12.1%
1.2.2. Operating Ratio

Measures how efficient Bgi is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Diagnostics & Research industry mean).
  • An Operation Ratio of 1.37 means that the operating costs are ¥1.37 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of BGI Genomics Co Ltd:

  • The MRQ is 1.374. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.452. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.374TTM1.452-0.079
TTM1.452YOY1.283+0.170
TTM1.4525Y1.278+0.174
5Y1.27810Y1.022+0.257
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ1.3741.310+0.064
TTM1.4521.303+0.149
YOY1.2831.240+0.043
5Y1.2781.270+0.008
10Y1.0221.228-0.206

1.3. Liquidity of BGI Genomics Co Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Bgi is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Diagnostics & Research industry mean).
  • A Current Ratio of 2.41 means the company has ¥2.41 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of BGI Genomics Co Ltd:

  • The MRQ is 2.406. The company is able to pay all its short-term debts. +1
  • The TTM is 2.593. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.406TTM2.593-0.187
TTM2.593YOY3.187-0.593
TTM2.5935Y2.975-0.382
5Y2.97510Y2.240+0.735
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ2.4062.194+0.212
TTM2.5932.366+0.227
YOY3.1872.753+0.434
5Y2.9752.989-0.014
10Y2.2403.000-0.760
1.3.2. Quick Ratio

Measures if Bgi is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Bgi to the Diagnostics & Research industry mean.
  • A Quick Ratio of 0.67 means the company can pay off ¥0.67 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of BGI Genomics Co Ltd:

  • The MRQ is 0.667. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.709. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.667TTM0.709-0.043
TTM0.709YOY0.885-0.176
TTM0.7095Y0.978-0.268
5Y0.97810Y1.013-0.035
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6671.273-0.606
TTM0.7091.355-0.646
YOY0.8851.563-0.678
5Y0.9781.952-0.974
10Y1.0132.127-1.114

1.4. Solvency of BGI Genomics Co Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Bgi assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Bgi to Diagnostics & Research industry mean.
  • A Debt to Asset Ratio of 0.27 means that Bgi assets are financed with 26.5% credit (debt) and the remaining percentage (100% - 26.5%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of BGI Genomics Co Ltd:

  • The MRQ is 0.265. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.257. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.265TTM0.257+0.008
TTM0.257YOY0.282-0.025
TTM0.2575Y0.299-0.042
5Y0.29910Y0.253+0.046
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2650.425-0.160
TTM0.2570.411-0.154
YOY0.2820.393-0.111
5Y0.2990.450-0.151
10Y0.2530.448-0.195
1.4.2. Debt to Equity Ratio

Measures if Bgi is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Bgi to the Diagnostics & Research industry mean.
  • A Debt to Equity ratio of 36.6% means that company has ¥0.37 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of BGI Genomics Co Ltd:

  • The MRQ is 0.366. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.351. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.366TTM0.351+0.015
TTM0.351YOY0.398-0.047
TTM0.3515Y0.451-0.100
5Y0.45110Y0.363+0.088
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3660.606-0.240
TTM0.3510.571-0.220
YOY0.3980.606-0.208
5Y0.4510.637-0.186
10Y0.3630.730-0.367

2. Market Valuation of BGI Genomics Co Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Bgi generates.

  • Above 15 is considered overpriced but always compare Bgi to the Diagnostics & Research industry mean.
  • A PE ratio of 220.28 means the investor is paying ¥220.28 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of BGI Genomics Co Ltd:

  • The EOD is 174.759. Based on the earnings, the company is expensive. -2
  • The MRQ is 220.285. Based on the earnings, the company is expensive. -2
  • The TTM is 448.604. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD174.759MRQ220.285-45.526
MRQ220.285TTM448.604-228.319
TTM448.604YOY43.405+405.199
TTM448.6045Y183.450+265.154
5Y183.45010Y140.131+43.318
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD174.759-0.202+174.961
MRQ220.285-0.402+220.687
TTM448.604-0.119+448.723
YOY43.405-0.003+43.408
5Y183.4502.211+181.239
10Y140.1314.907+135.224
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of BGI Genomics Co Ltd:

  • The EOD is -61.645. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -77.704. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -38.288. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-61.645MRQ-77.704+16.059
MRQ-77.704TTM-38.288-39.416
TTM-38.288YOY-5.703-32.585
TTM-38.2885Y1.580-39.868
5Y1.58010Y-25.320+26.899
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD-61.645-0.179-61.466
MRQ-77.704-0.417-77.287
TTM-38.288-1.288-37.000
YOY-5.703-2.547-3.156
5Y1.580-1.999+3.579
10Y-25.320-2.372-22.948
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Bgi is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Diagnostics & Research industry mean).
  • A PB ratio of 1.99 means the investor is paying ¥1.99 for each ¥1 in book value.

Let's take a look of the Price to Book Ratio trends of BGI Genomics Co Ltd:

  • The EOD is 1.576. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.986. Based on the equity, the company is underpriced. +1
  • The TTM is 2.346. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.576MRQ1.986-0.410
MRQ1.986TTM2.346-0.360
TTM2.346YOY2.707-0.361
TTM2.3465Y5.032-2.685
5Y5.03210Y5.468-0.436
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD1.5761.877-0.301
MRQ1.9862.437-0.451
TTM2.3462.235+0.111
YOY2.7073.239-0.532
5Y5.0323.450+1.582
10Y5.4684.040+1.428
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of BGI Genomics Co Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.214-0.133-38%0.473-145%0.695-131%0.755-128%
Book Value Per Share--24.16924.394-1%23.927+1%19.009+27%15.288+58%
Current Ratio--2.4062.593-7%3.187-24%2.975-19%2.240+7%
Debt To Asset Ratio--0.2650.257+3%0.282-6%0.299-11%0.253+5%
Debt To Equity Ratio--0.3660.351+4%0.398-8%0.451-19%0.363+1%
Dividend Per Share--0.0030.450-99%0.325-99%0.194-98%0.176-98%
Eps--0.0540.037+46%0.491-89%0.568-90%0.431-87%
Free Cash Flow Per Share---0.154-0.500+224%-0.683+342%0.367-142%0.209-174%
Free Cash Flow To Equity Per Share---0.154-0.906+487%-1.404+809%0.419-137%0.467-133%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---131.325--------
Intrinsic Value_10Y_min---108.951--------
Intrinsic Value_1Y_max---1.815--------
Intrinsic Value_1Y_min---1.776--------
Intrinsic Value_3Y_max---14.098--------
Intrinsic Value_3Y_min---13.285--------
Intrinsic Value_5Y_max---36.806--------
Intrinsic Value_5Y_min---33.418--------
Market Cap15761844510.720-26%19867887600.00023713151679.250-16%26636421599.563-25%34799212734.919-43%31675682688.124-37%
Net Profit Margin--0.0190.022-16%0.129-86%0.126-85%0.142-87%
Operating Margin---0.006-100%0.156-100%0.145-100%0.101-100%
Operating Ratio--1.3741.452-5%1.283+7%1.278+7%1.022+34%
Pb Ratio1.576-26%1.9862.346-15%2.707-27%5.032-61%5.468-64%
Pe Ratio174.759-26%220.285448.604-51%43.405+408%183.450+20%140.131+57%
Price Per Share38.080-26%48.00057.290-16%64.353-25%84.074-43%76.527-37%
Price To Free Cash Flow Ratio-61.645+21%-77.704-38.288-51%-5.703-93%1.580-5019%-25.320-67%
Price To Total Gains Ratio-180.327+21%-227.303184.832-223%-662.898+192%-20.370-91%52.382-534%
Quick Ratio--0.6670.709-6%0.885-25%0.978-32%1.013-34%
Return On Assets--0.0020.002-3%0.015-89%0.022-92%0.020-92%
Return On Equity--0.0020.002-2%0.021-89%0.034-93%0.030-92%
Total Gains Per Share---0.2110.317-167%0.797-126%0.888-124%0.931-123%
Usd Book Value--1382555603.6361395399207.506-1%1368670430.722+1%1087389394.216+27%874497366.958+58%
Usd Book Value Change Per Share---0.030-0.018-38%0.065-145%0.096-131%0.104-128%
Usd Book Value Per Share--3.3403.371-1%3.307+1%2.627+27%2.113+58%
Usd Dividend Per Share--0.0000.062-99%0.045-99%0.027-98%0.024-98%
Usd Eps--0.0080.005+46%0.068-89%0.078-90%0.060-87%
Usd Free Cash Flow---8833976.432-28594179.716+224%-39049850.331+342%20965690.663-142%10847974.266-181%
Usd Free Cash Flow Per Share---0.021-0.069+224%-0.094+342%0.051-142%0.029-174%
Usd Free Cash Flow To Equity Per Share---0.021-0.125+487%-0.194+809%0.058-137%0.065-133%
Usd Market Cap2178286911.382-26%2745742066.3203277157562.072-16%3681153465.060-25%4809251199.966-43%4377579347.499-37%
Usd Price Per Share5.263-26%6.6347.917-16%8.894-25%11.619-43%10.576-37%
Usd Profit--3116125.0433209708.698-3%27740980.844-89%32642692.860-90%24768368.299-87%
Usd Revenue--166694779.005150279967.016+11%243443863.405-32%202874480.734-18%153719373.457+8%
Usd Total Gains Per Share---0.0290.044-167%0.110-126%0.123-124%0.129-123%
 EOD+4 -4MRQTTM+13 -22YOY+14 -215Y+8 -2710Y+8 -27

3.2. Fundamental Score

Let's check the fundamental score of BGI Genomics Co Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15174.759
Price to Book Ratio (EOD)Between0-11.576
Net Profit Margin (MRQ)Greater than00.019
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.667
Current Ratio (MRQ)Greater than12.406
Debt to Asset Ratio (MRQ)Less than10.265
Debt to Equity Ratio (MRQ)Less than10.366
Return on Equity (MRQ)Greater than0.150.002
Return on Assets (MRQ)Greater than0.050.002
Total4/10 (40.0%)

3.3. Technical Score

Let's check the technical score of BGI Genomics Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5035.595
Ma 20Greater thanMa 5040.478
Ma 50Greater thanMa 10042.085
Ma 100Greater thanMa 20044.593
OpenGreater thanClose38.310
Total1/5 (20.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in CNY. All numbers in thousands.

Summary
Total Assets13,613,008
Total Liabilities3,608,988
Total Stockholder Equity9,859,238
 As reported
Total Liabilities 3,608,988
Total Stockholder Equity+ 9,859,238
Total Assets = 13,613,008

Assets

Total Assets13,613,008
Total Current Assets7,932,793
Long-term Assets5,680,215
Total Current Assets
Cash And Cash Equivalents 4,732,376
Short-term Investments 753,575
Net Receivables 1,443,947
Inventory 602,182
Other Current Assets 293,040
Total Current Assets  (as reported)7,932,793
Total Current Assets  (calculated)7,825,120
+/- 107,673
Long-term Assets
Property Plant Equipment 3,190,423
Goodwill 47,109
Intangible Assets 579,938
Long-term Assets Other 152,636
Long-term Assets  (as reported)5,680,215
Long-term Assets  (calculated)3,970,107
+/- 1,710,107

Liabilities & Shareholders' Equity

Total Current Liabilities3,297,040
Long-term Liabilities311,947
Total Stockholder Equity9,859,238
Total Current Liabilities
Accounts payable 864,595
Other Current Liabilities 28,760
Total Current Liabilities  (as reported)3,297,040
Total Current Liabilities  (calculated)893,355
+/- 2,403,685
Long-term Liabilities
Long term Debt 215,678
Capital Lease Obligations Min Short Term Debt67,749
Long-term Liabilities  (as reported)311,947
Long-term Liabilities  (calculated)283,427
+/- 28,520
Total Stockholder Equity
Retained Earnings 4,617,985
Total Stockholder Equity (as reported)9,859,238
Total Stockholder Equity (calculated)4,617,985
+/- 5,241,253
Other
Capital Stock413,914
Common Stock Shares Outstanding 413,914
Net Invested Capital 10,074,916
Net Working Capital 4,635,753
Property Plant and Equipment Gross 3,190,423



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-03-312015-12-312015-06-302015-03-312014-12-312013-12-312012-12-31
> Total Assets 
1,003,678
1,497,402
2,048,908
3,649,964
3,649,964
3,910,857
0
4,230,094
0
4,317,486
4,972,624
5,111,813
5,049,886
5,240,014
5,321,490
5,251,400
5,308,511
5,445,458
5,628,616
5,909,118
7,102,552
10,045,158
10,921,603
11,195,041
13,452,172
13,752,446
14,252,521
14,254,030
13,425,986
13,459,152
13,882,090
14,375,514
13,673,807
13,605,407
13,463,454
13,613,008
13,613,00813,463,45413,605,40713,673,80714,375,51413,882,09013,459,15213,425,98614,254,03014,252,52113,752,44613,452,17211,195,04110,921,60310,045,1587,102,5525,909,1185,628,6165,445,4585,308,5115,251,4005,321,4905,240,0145,049,8865,111,8134,972,6244,317,48604,230,09403,910,8573,649,9643,649,9642,048,9081,497,4021,003,678
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
3,676,460
3,708,114
3,281,881
3,329,900
3,085,103
3,257,239
3,203,507
4,375,585
7,375,109
8,089,999
8,416,943
10,600,926
10,790,437
11,235,949
11,034,760
10,210,192
10,066,005
10,094,618
9,765,736
8,948,074
8,382,696
8,050,501
7,932,793
7,932,7938,050,5018,382,6968,948,0749,765,73610,094,61810,066,00510,210,19211,034,76011,235,94910,790,43710,600,9268,416,9438,089,9997,375,1094,375,5853,203,5073,257,2393,085,1033,329,9003,281,8813,708,1143,676,4600000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
1,390,426
1,191,846
1,070,061
1,124,377
855,973
748,068
735,327
1,466,210
3,111,980
4,041,619
5,430,072
7,081,250
6,304,768
7,039,762
6,590,287
6,079,104
6,363,442
5,956,122
5,157,744
5,333,230
5,024,804
5,114,888
4,732,376
4,732,3765,114,8885,024,8045,333,2305,157,7445,956,1226,363,4426,079,1046,590,2877,039,7626,304,7687,081,2505,430,0724,041,6193,111,9801,466,210735,327748,068855,9731,124,3771,070,0611,191,8461,390,4260000000000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
817,437
0
505,364
18,000
113,791
93,103
482,220
542,463
798,374
390,507
0
260,700
1,056,645
1,180,458
2,049,070
1,371,649
1,000,689
1,064,503
1,231,947
929,266
788,317
431,676
753,575
753,575431,676788,317929,2661,231,9471,064,5031,000,6891,371,6492,049,0701,180,4581,056,645260,7000390,507798,374542,463482,22093,103113,79118,000505,3640817,4370000000000000
       Net Receivables 
419,985
490,904
575,612
601,091
601,091
491,498
0
615,349
0
741,909
824,066
830,215
921,835
1,087,106
1,279,672
1,296,658
1,422,078
1,337,792
1,547,009
1,335,657
1,392,746
1,585,357
2,241,478
1,692,744
1,730,018
2,182,895
1,676,680
1,293,916
1,384,179
1,424,696
1,533,789
2,390,019
1,558,273
1,696,236
1,526,918
1,443,947
1,443,9471,526,9181,696,2361,558,2732,390,0191,533,7891,424,6961,384,1791,293,9161,676,6802,182,8951,730,0181,692,7442,241,4781,585,3571,392,7461,335,6571,547,0091,337,7921,422,0781,296,6581,279,6721,087,106921,835830,215824,066741,9090615,3490491,498601,091601,091575,612490,904419,985
       Other Current Assets 
9,221
12,828
42,960
29,305
29,305
61,511
0
147,179
0
97,189
2,040,023
148,260
1,492,710
203,124
1,031,063
167,892
177,783
129,386
124,513
307,332
357,385
594,430
306,465
284,307
321,235
272,805
286,403
217,197
332,727
245,222
294,598
248,549
234,924
261,563
196,414
293,040
293,040196,414261,563234,924248,549294,598245,222332,727217,197286,403272,805321,235284,307306,465594,430357,385307,332124,513129,386177,783167,8921,031,063203,1241,492,710148,2602,040,02397,1890147,179061,51129,30529,30542,96012,8289,221
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,978,612
2,360,356
2,371,377
2,705,611
2,726,967
2,670,050
2,831,604
2,778,098
2,851,246
2,962,009
3,016,573
3,219,270
3,215,794
3,393,147
3,787,471
4,609,778
4,725,732
5,222,710
5,412,953
5,680,215
5,680,2155,412,9535,222,7104,725,7324,609,7783,787,4713,393,1473,215,7943,219,2703,016,5732,962,0092,851,2462,778,0982,831,6042,670,0502,726,9672,705,6112,371,3772,360,3561,978,6120000000000000000
       Property Plant Equipment 
135,809
276,946
407,524
336,646
336,646
430,693
0
556,640
0
607,760
680,213
739,439
781,041
827,403
867,883
1,152,522
1,122,447
1,192,562
1,200,826
1,310,585
1,269,963
1,279,573
1,349,768
1,287,388
1,301,730
1,380,149
1,358,427
1,399,695
1,388,992
1,514,458
1,633,394
2,190,355
2,232,463
2,768,505
2,911,059
3,190,423
3,190,4232,911,0592,768,5052,232,4632,190,3551,633,3941,514,4581,388,9921,399,6951,358,4271,380,1491,301,7301,287,3881,349,7681,279,5731,269,9631,310,5851,200,8261,192,5621,122,4471,152,522867,883827,403781,041739,439680,213607,7600556,6400430,693336,646336,646407,524276,946135,809
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
47,109
47,109
47,109
47,109
47,109
47,109
47,109
47,109
47,109
47,109
47,109
47,109
47,109
47,109
47,109
47,109
47,109
47,109
47,109
47,109
47,109
47,10947,10947,10947,10947,10947,10947,10947,10947,10947,10947,10947,10947,10947,10947,10947,10947,10947,10947,10947,10947,109000000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
226,146
238,966
278,616
289,193
385,669
409,842
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000409,842385,669289,193278,616238,966226,1460000000000000
       Intangible Assets 
121
213,037
203,254
196,664
196,664
189,236
0
171,666
0
163,214
160,353
160,143
155,835
151,538
149,788
156,516
158,014
163,983
162,843
177,805
176,724
174,699
169,263
179,369
218,752
247,518
273,019
323,211
322,586
318,283
460,540
528,954
522,367
531,216
542,442
579,938
579,938542,442531,216522,367528,954460,540318,283322,586323,211273,019247,518218,752179,369169,263174,699176,724177,805162,843163,983158,014156,516149,788151,538155,835160,143160,353163,2140171,6660189,236196,664196,664203,254213,037121
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
211,718
439,657
368,334
382,611
373,960
299,014
1,650,806
247,128
253,678
181,617
189,496
185,078
174,184
195,829
179,226
168,817
205,948
180,513
182,640
152,636
152,636182,640180,513205,948168,817179,226195,829174,184185,078189,496181,617253,678247,1281,650,806299,014373,960382,611368,334439,657211,7180000000000000000
> Total Liabilities 
853,307
899,457
583,402
673,422
673,422
741,370
0
777,521
0
778,595
820,992
853,878
718,417
895,568
909,061
999,040
971,904
1,056,114
1,074,748
1,508,079
2,553,568
4,367,950
4,053,299
5,169,300
4,882,533
4,579,362
4,875,027
4,812,756
3,998,347
3,580,137
3,798,206
4,151,857
3,448,719
3,539,436
3,370,712
3,608,988
3,608,9883,370,7123,539,4363,448,7194,151,8573,798,2063,580,1373,998,3474,812,7564,875,0274,579,3624,882,5335,169,3004,053,2994,367,9502,553,5681,508,0791,074,7481,056,114971,904999,040909,061895,568718,417853,878820,992778,5950777,5210741,370673,422673,422583,402899,457853,307
   > Total Current Liabilities 
832,871
860,719
531,047
630,164
630,164
687,397
0
731,480
0
743,145
785,151
813,082
673,940
840,587
855,885
944,313
912,168
946,525
976,096
1,134,498
1,762,394
3,001,115
2,633,138
3,802,121
3,455,026
3,116,862
3,405,485
3,383,517
3,196,789
2,760,975
2,942,737
3,943,939
3,278,575
3,240,278
3,036,845
3,297,040
3,297,0403,036,8453,240,2783,278,5753,943,9392,942,7372,760,9753,196,7893,383,5173,405,4853,116,8623,455,0263,802,1212,633,1383,001,1151,762,3941,134,498976,096946,525912,168944,313855,885840,587673,940813,082785,151743,1450731,4800687,397630,164630,164531,047860,719832,871
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
31,063
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000031,063000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
31,063
0
0
0
0
240,000
249,100
288,200
563,296
326,691
25,025
20,035
5,006
10,011
5,005
0
0
0
0
0
0
0000005,00510,0115,00620,03525,025326,691563,296288,200249,100240,000000031,063000000000000000
       Accounts payable 
227,161
398,246
55,668
97,007
97,007
46,798
0
57,925
0
109,245
181,200
119,658
91,846
169,857
174,905
139,034
177,302
214,305
196,359
221,156
192,124
618,721
743,929
873,231
1,138,083
854,990
844,774
805,322
422,973
715,858
901,637
1,024,844
794,675
1,027,776
735,240
864,595
864,595735,2401,027,776794,6751,024,844901,637715,858422,973805,322844,774854,9901,138,083873,231743,929618,721192,124221,156196,359214,305177,302139,034174,905169,85791,846119,658181,200109,245057,925046,79897,00797,00755,668398,246227,161
       Other Current Liabilities 
604,810
460,024
468,070
520,067
520,067
632,470
0
670,556
0
630,900
595,951
685,423
574,093
542,655
669,807
533,313
32,821
5,850
2,532
626,495
1,269,290
1,727,549
1,557,768
1,378,761
1,920,522
1,568,030
2,383,244
1,793,766
1,878,030
1,279,651
1,718,059
30,010
2,406,872
1,643,501
28,580
28,760
28,76028,5801,643,5012,406,87230,0101,718,0591,279,6511,878,0301,793,7662,383,2441,568,0301,920,5221,378,7611,557,7681,727,5491,269,290626,4952,5325,85032,821533,313669,807542,655574,093685,423595,951630,9000670,5560632,470520,067520,067468,070460,024604,810
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
59,736
109,589
98,652
373,581
791,174
1,366,835
1,420,161
1,367,178
1,427,507
1,462,500
1,469,542
1,429,240
801,558
819,163
855,469
207,918
170,144
299,158
333,867
311,947
311,947333,867299,158170,144207,918855,469819,163801,5581,429,2401,469,5421,462,5001,427,5071,367,1781,420,1611,366,835791,174373,58198,652109,58959,7360000000000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-31,063
0
0
0
0
0
0
0
0
84,121
119,600
101,619
84,441
72,733
76,538
99,017
136,680
121,110
115,113
83,885
67,749
67,74983,885115,113121,110136,68099,01776,53872,73384,441101,619119,60084,12100000000-31,063000000000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
15,000
15,000
15,000
0
127,400
697,817
0
0
635,751
10,423
670,756
0
687,092
0
0
0
0
0
0
0
0000000687,0920670,75610,423635,75100697,817127,400015,00015,00015,0000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
80,972
77,869
73,232
69,526
77,898
71,462
89,060
94,727
92,246
87,013
95,888
93,336
98,023
53,580
177,654
179,177
81,460
189,217
0
0
238,411
0
0
00238,41100189,21781,460179,177177,65453,58098,02393,33695,88887,01392,24694,72789,06071,46277,89869,52673,23277,86980,9720000000000000
> Total Stockholder Equity
113,244
399,936
1,185,947
2,898,896
2,898,896
3,095,018
3,169,487
3,359,762
3,452,573
3,441,445
4,044,326
4,148,625
4,218,762
4,231,772
4,289,840
4,164,960
4,248,689
4,300,315
4,460,786
4,314,049
4,464,906
5,582,228
6,750,007
5,910,105
8,446,212
9,058,763
9,254,347
9,318,408
9,303,640
9,753,067
9,954,132
10,078,568
10,081,356
9,920,010
9,947,114
9,859,238
9,859,2389,947,1149,920,01010,081,35610,078,5689,954,1329,753,0679,303,6409,318,4089,254,3479,058,7638,446,2125,910,1056,750,0075,582,2284,464,9064,314,0494,460,7864,300,3154,248,6894,164,9604,289,8404,231,7724,218,7624,148,6254,044,3263,441,4453,452,5733,359,7623,169,4873,095,0182,898,8962,898,8961,185,947399,936113,244
   Common Stock
2,000
20,000
85,859
360,000
360,000
360,000
0
360,000
0
360,000
400,100
400,100
400,100
400,100
400,100
400,100
400,100
400,100
400,100
400,100
400,100
400,100
400,100
400,100
413,914
413,914
413,914
413,914
413,914
413,914
413,914
0
0
413,914
0
0
00413,91400413,914413,914413,914413,914413,914413,914413,914400,100400,100400,100400,100400,100400,100400,100400,100400,100400,100400,100400,100400,100400,100360,0000360,0000360,000360,000360,00085,85920,0002,000
   Retained Earnings 
56,313
47,153
75,273
140,771
140,771
211,914
0
461,805
0
544,866
666,231
751,897
852,647
839,612
872,007
938,492
969,086
984,284
1,056,389
1,056,323
1,196,342
2,772,526
3,786,352
3,159,513
3,684,494
4,255,669
4,441,128
4,487,788
4,818,203
5,093,688
5,091,660
4,941,366
4,982,714
4,787,166
4,595,437
4,617,985
4,617,9854,595,4374,787,1664,982,7144,941,3665,091,6605,093,6884,818,2034,487,7884,441,1284,255,6693,684,4943,159,5133,786,3522,772,5261,196,3421,056,3231,056,389984,284969,086938,492872,007839,612852,647751,897666,231544,8660461,8050211,914140,771140,77175,27347,15356,313
   Capital Surplus 000000000000000000000000000000000000
   Treasury Stock000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
23,803
49,477
23,018
-4,751
26,694
38,907
49,976
60,814
68,426
736
-78,610
-68,073
-68,418
-63,801
-152,566
-174,717
-9,914
193,179
0
0
313,415
0
0
00313,41500193,179-9,914-174,717-152,566-63,801-68,418-68,073-78,61073668,42660,81449,97638,90726,694-4,75123,01849,47723,8030000000000000



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue4,349,637
Cost of Revenue-2,179,031
Gross Profit2,170,6072,170,607
 
Operating Income (+$)
Gross Profit2,170,607
Operating Expense-4,118,287
Operating Income231,350-1,947,680
 
Operating Expense (+$)
Research Development528,925
Selling General Administrative1,164,871
Selling And Marketing Expenses0
Operating Expense4,118,2871,693,796
 
Net Interest Income (+$)
Interest Income152,043
Interest Expense-91,560
Other Finance Cost-3,242
Net Interest Income57,240
 
Pretax Income (+$)
Operating Income231,350
Net Interest Income57,240
Other Non-Operating Income Expenses0
Income Before Tax (EBT)115,536231,350
EBIT - interestExpense = -91,560
92,900
184,461
Interest Expense91,560
Earnings Before Interest and Taxes (EBIT)0207,096
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax115,536
Tax Provision-21,854
Net Income From Continuing Ops93,68293,682
Net Income92,900
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net0-57,240
 

Technical Analysis of Bgi
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Bgi. The general trend of Bgi is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Bgi's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of BGI Genomics Co Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 41.86 < 45.55 < 46.00.

The bearish price targets are: 33.00.

Tweet this
BGI Genomics Co Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of BGI Genomics Co Ltd. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

BGI Genomics Co Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of BGI Genomics Co Ltd. The current macd is -1.3207152.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Bgi price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Bgi. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Bgi price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
BGI Genomics Co Ltd Daily Moving Average Convergence/Divergence (MACD) ChartBGI Genomics Co Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of BGI Genomics Co Ltd. The current adx is 25.90.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -4/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Bgi shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bearish trend. The ADX is trending up, so the bearish trend is strengthening.
BGI Genomics Co Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of BGI Genomics Co Ltd. The current sar is 39.31.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
BGI Genomics Co Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of BGI Genomics Co Ltd. The current rsi is 35.60. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
BGI Genomics Co Ltd Daily Relative Strength Index (RSI) ChartBGI Genomics Co Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of BGI Genomics Co Ltd. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Bgi price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
BGI Genomics Co Ltd Daily Stochastic Oscillator ChartBGI Genomics Co Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of BGI Genomics Co Ltd. The current cci is -102.92603724.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
BGI Genomics Co Ltd Daily Commodity Channel Index (CCI) ChartBGI Genomics Co Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of BGI Genomics Co Ltd. The current cmo is -34.53049974.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
BGI Genomics Co Ltd Daily Chande Momentum Oscillator (CMO) ChartBGI Genomics Co Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of BGI Genomics Co Ltd. The current willr is -92.93598234.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
BGI Genomics Co Ltd Daily Williams %R ChartBGI Genomics Co Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of BGI Genomics Co Ltd.

BGI Genomics Co Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of BGI Genomics Co Ltd. The current atr is 1.22497185.

BGI Genomics Co Ltd Daily Average True Range (ATR) ChartBGI Genomics Co Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of BGI Genomics Co Ltd. The current obv is -33,159,304.

BGI Genomics Co Ltd Daily On-Balance Volume (OBV) ChartBGI Genomics Co Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of BGI Genomics Co Ltd. The current mfi is 24.10.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
BGI Genomics Co Ltd Daily Money Flow Index (MFI) ChartBGI Genomics Co Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for BGI Genomics Co Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-22RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-27SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-11-28STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-29STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-01STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-05STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-06CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-08DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-12STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-15STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-25MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-26STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-28SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-29MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-03MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-01-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-08BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-11RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-01-12STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-17BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-22STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-24RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-01-25SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-30SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-31BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-02BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-07ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-19DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-02-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-27DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-06WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-07DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-14CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-18MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-19CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-20WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-03-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-22CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-25MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-27BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-02STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-03CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-08BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-11MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-18MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-19STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

BGI Genomics Co Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of BGI Genomics Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5035.595
Ma 20Greater thanMa 5040.478
Ma 50Greater thanMa 10042.085
Ma 100Greater thanMa 20044.593
OpenGreater thanClose38.310
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Bgi with someone you think should read this too:
  • Are you bullish or bearish on Bgi? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Bgi? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about BGI Genomics Co Ltd

I send you an email if I find something interesting about BGI Genomics Co Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about BGI Genomics Co Ltd.

Receive notifications about BGI Genomics Co Ltd in your mailbox!